Trenbolone Powder CAS 10161-33-8

Qunbolong can strongly bind to androgen receptors, stimulate protein synthesis and muscle repair processes. This characteristic makes it potentially valuable in the treatment of muscle atrophy diseases such as muscular dystrophy, cancer cachexia, etc. In these diseases, the patient's muscle tissue gradually shrinks, leading to a decrease in strength and quality of life. Qunbolong may help slow down the process of muscle atrophy and improve patients' quality of life by promoting protein synthesis and muscle repair. However, due to the significant side effects of tranbolone, including masculinization (such as acne, hair loss, body hair growth, etc.) and cardiovascular system side effects (such as elevated blood pressure, abnormal blood lipids, etc.), its use in the treatment of muscle atrophy diseases is strictly limited. At present, Qunbolong is not the preferred treatment for these diseases, and is only considered for use when other treatment methods are ineffective, and the risks and benefits need to be strictly evaluated.

Studies have shown that Trenbolone has a preventive effect on specific diseases such as mad cow disease. Mad cow disease is a neurological disorder caused by prions, posing a serious threat to human and animal health. Qunbolong may help reduce the risk of mad cow disease by inhibiting the replication and transmission of prions. However, this discovery is still in the research stage and has not been widely validated and applied. In addition, other side effects of Qunbolong may limit its application in disease prevention. Therefore, currently tranbolone is not the preferred drug for preventing specific diseases.

During the bodybuilding preparation period, athletes need to maintain muscle mass at extremely low body fat percentage, which is extremely challenging for traditional steroids. Qunbolong has become the preferred candidate for the race due to its following characteristics:
Powerful weight loss: Qunbolong can directly activate androgen receptors on adipocytes, promote fat breakdown, and inhibit adipocyte differentiation, reducing fat production from the source.
Muscle protection: Under extreme dieting conditions, Qunbolong can prevent muscle breakdown by inhibiting cortisol and increasing IGF-1 levels, helping athletes maintain muscle mass even with low calorie intake.
Improving muscle appearance: Qunbolong can reduce extracellular water, making muscle lines clearer and blood vessels more prominent, significantly enhancing stage performance.

Although endurance sports such as marathons and cycling require strict weight control, Qunbolong is less commonly used by endurance athletes due to the following risks:
Cardiovascular burden: Trombolone may increase low-density lipoprotein (LDL) and reduce high-density lipoprotein (HDL), increase the risk of atherosclerosis, and pose a threat to the cardiovascular system of endurance athletes.
Respiratory depression: Some users have reported that tranexamic acid may cause dry cough and difficulty breathing, which may be related to bronchoconstriction caused by prostaglandin activation, which may affect endurance performance.

The impact of Qunbolong on the cardiovascular system presents a "double blow" characteristic: in the short term, it triggers blood pressure fluctuations through hormone action, and in the long term, it accelerates the process of arteriosclerosis through metabolic disorders. It inhibits potassium ion channels in vascular smooth muscle cells, leading to vasoconstriction and increased peripheral resistance. At the same time, its potent androgenic activity stimulates the secretion of erythropoietin (EPO), increasing hematocrit by 4% -8% and blood viscosity, further exacerbating cardiac afterload. It can also reduce the potassium ion concentration in myocardial cells, prolong the duration of action potentials, and induce malignant arrhythmias such as premature ventricular contractions and ventricular tachycardia.

The effects of Qunbolong on the nervous system exhibit a "dose-dependent" characteristic: at low doses, it mainly manifests as emotional changes, while at high doses, it may cause organic damage. Qunbolong can penetrate the blood-brain barrier and directly act on the hypothalamic pituitary adrenal axis (HPA axis), causing fluctuations in cortisol levels. Abusers often experience "manic like" symptoms, characterized by irritability and increased aggression (with an incidence rate of about 65%), accompanied by anxiety and depression (with an incidence rate of about 40%). This emotional fluctuation may last for weeks to months after discontinuing medication. It also shortens deep sleep (NREM sleep) time by inhibiting gamma aminobutyric acid (GABA) receptor function. The average number of awakenings per night for abusers increases by 2-3 times, and their sleep efficiency decreases by 15% -20%. Long term sleep deprivation can further exacerbate emotional disorders and form a vicious cycle.